These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 6441853)
1. [Usefulness of a radiolucent spacer in radiation therapy for cancer of the tongue]. Niwa K; Morita K; Kanazawa H; Yokoi M Gan No Rinsho; 1984 Dec; 30(15):1861-5. PubMed ID: 6441853 [TBL] [Abstract][Full Text] [Related]
2. Techniques for making spacers in interstitial brachytherapy for tongue cancer. Tamamoto M; Fujita M; Yamamoto T; Hamada T Int J Prosthodont; 1996; 9(1):95-8. PubMed ID: 8630183 [TBL] [Abstract][Full Text] [Related]
3. Factors affecting mandibular complications in low dose rate brachytherapy for oral tongue carcinoma with special reference to spacer. Miura M; Takeda M; Sasaki T; Inoue T; Nakayama T; Fukuda H; Hoshi A; Hoshina M; Shibuya H Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):763-70. PubMed ID: 9652836 [TBL] [Abstract][Full Text] [Related]
5. Dose-reducing effect of Lipowitz metal-embedded spacers in interstitial brachytherapy for carcinoma of the mobile tongue. Fujita M; Hirokawa Y; Tamamoto M; Kashiwado K; Akagi Y; Kashimoto K; Wada T Oral Surg Oral Med Oral Pathol; 1994 Jun; 77(6):589-93. PubMed ID: 8065721 [TBL] [Abstract][Full Text] [Related]
6. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma. Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696 [TBL] [Abstract][Full Text] [Related]
7. Preventing Complications from High-Dose Rate Brachytherapy when Treating Mobile Tongue Cancer via the Application of a Modular Lead-Lined Spacer. Murakami S; Verdonschot RG; Kakimoto N; Sumida I; Fujiwara M; Ogawa K; Furukawa S PLoS One; 2016; 11(4):e0154226. PubMed ID: 27128434 [TBL] [Abstract][Full Text] [Related]
8. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587 [TBL] [Abstract][Full Text] [Related]
9. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 2. Phase III trial of HDR versus LDR interstitial brachytherapy for T1-T2N0 carcinoma of the mobile tongue. Inoue T; Inoue T Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():291-5. PubMed ID: 10895169 [No Abstract] [Full Text] [Related]
10. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 3. Comparative study of early mucosal reaction and late tongue atrophy between LDR and HDR Ir-192 interstitial brachytherapy for patients with carcinoma of the mobile tongue. Inoue T; Inoue T; Yoshioka Y; Yoshida K Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():296-300. PubMed ID: 10895170 [No Abstract] [Full Text] [Related]
11. High dose rate interstitial brachytherapy for mobile tongue cancer: Part 1. Phase I/II study of HDR hyperfractionated interstitial brachytherapy for oral cancer. Inoue T; Inoue T; Teshima T Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():287-90. PubMed ID: 10895168 [No Abstract] [Full Text] [Related]
12. [Dose, time and volume factors in interstitial therapy of tongue neoplasms with cf-252]. Vtiurin BM; Ivanov VN; Abdulkadyrov SA; Ivanova LF Med Radiol (Mosk); 1982 Feb; 27(2):3-8. PubMed ID: 7070237 [No Abstract] [Full Text] [Related]
13. Base-of-tongue cancer: survival, function, and quality of life after external-beam irradiation and brachytherapy. Robertson ML; Gleich LL; Barrett WL; Gluckman JL Laryngoscope; 2001 Aug; 111(8):1362-5. PubMed ID: 11568569 [TBL] [Abstract][Full Text] [Related]
14. [Clinical experience with high dose rate afterloading interstitial radiation--a preliminary report]. Itami J; Saegusa K; Okada J; Fujimoto H; Miyagawa K; Uno K; Miyoshi T; Arimizu N; Mamiya T Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):80-6. PubMed ID: 3084688 [No Abstract] [Full Text] [Related]
15. [The interstitial radiation therapy of cancer of the tongue and mucosa of the floor of the mouth]. Zamiatin OA; Vakhramova MP; Razorenova EV Vopr Onkol; 1995; 41(2):112-4. PubMed ID: 7483404 [No Abstract] [Full Text] [Related]
16. Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma. Guinot JL; Santos M; Tortajada MI; Carrascosa M; Estellés E; Vendrell JB; Muelas R; Chust ML; Mengual JL; Arribas L Brachytherapy; 2010; 9(3):227-34. PubMed ID: 20116340 [TBL] [Abstract][Full Text] [Related]
17. Clinical study of a spacer to help prevent osteoradionecrosis resulting from brachytherapy for tongue cancer. Obinata K; Ohmori K; Tuchiya K; Nishioka T; Shirato H; Nakamura M Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Feb; 95(2):246-50. PubMed ID: 12582367 [TBL] [Abstract][Full Text] [Related]